May 12, 2026 08:00AM

Apr 20, 2026 06:43AM

Apr 20, 2026 06:08AM

Apr 8, 2026 06:00AM

Apr 8, 2026 06:00AM

Mar 18, 2026 07:58AM

Mar 17, 2026 06:00AM AtaiBeckley publishes phase 2a data for depression treatment BPL-003

Mar 17, 2026 06:00AM

Mar 10, 2026 06:00AM

Mar 10, 2026 06:00AM

Mar 6, 2026 03:37PM

Mar 6, 2026 07:00AM

Mar 3, 2026 07:00AM

Mar 3, 2026 07:00AM AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Jan 16, 2026 07:00AM

Jan 13, 2026 07:02AM

Jan 8, 2026 07:06AM

Jan 8, 2026 07:00AM

Nov 14, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Nov 12, 2025 07:00AM

Nov 10, 2025 07:00AM

Nov 10, 2025 07:00AM

Nov 5, 2025 07:00AM

Oct 22, 2025 06:23AM

Oct 16, 2025 04:11PM

Oct 16, 2025 04:10PM atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

Sep 24, 2025 06:29AM

Sep 23, 2025 07:00AM

Sep 23, 2025 07:00AM

Aug 14, 2025 07:00AM

Jul 2, 2025 11:59AM

Jul 2, 2025 06:42AM

Jul 1, 2025 09:50AM Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

Jul 1, 2025 06:05AM

Jul 1, 2025 06:05AM

Jul 1, 2025 06:01AM

Jul 1, 2025 06:00AM

Nov 13, 2024 08:00AM

Jun 5, 2024 08:55AM

Jun 5, 2024 07:48AM Mind Medicine (MNMD) COMPASS Pathways (CMPS) Weakness Tied to FDA Panel Decision on MDMA drug

Oct 17, 2023 08:00AM

Jun 1, 2023 09:10AM

Dec 19, 2022 06:59AM

Dec 19, 2022 06:59AM

Dec 19, 2022 06:59AM

Oct 12, 2022 07:03AM

Oct 12, 2022 07:00AM atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD

Oct 12, 2022 07:00AM

322,208 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All